2 ml tirzepatide Injectable – 25 mg/mL 2.5mg Tirzepatide Injection at ₹
Description
These products are not intended to diagnose, treat, cure, or prevent any disease

Find information about Medicare coverage for weight loss medication

Health Canada has approved the first generic version of brand-name Ozempic.

In February 2026, the FDA publicly announced its intent to take action targeting mass-marketed, non-FDA-approved compounded GLP1 products, emphasizing that promotional claims implying equivalence to FDAapproved drugs can trigger enforcement risk
